New York Blood Center Enterprises (NYBCe) President and CEO Christopher D. Hillyer, MD has been recognized by 914INC. as one of Westchester’s top business leaders in its July/August 2026 issue. 914INC. is a part of Westchester Magazine.
The feature highlighted Dr. Hillyer’s leadership in transforming NYBCe into a more than $600 million enterprise spanning blood services, biomedical research, cellular therapies, and biomanufacturing. Since becoming President and CEO in 2009, Dr. Hillyer has helped guide NYBCe’s growth and expansion while advancing its mission to save and improve lives.
An internationally recognized expert in hematology, transfusion medicine, transplantation, and cellular therapies, Dr. Hillyer leads an organization that serves or collaborates with more than 75 million people and over 400 healthcare and research partners worldwide. The feature also offered readers a glimpse into Dr. Hillyer’s leadership philosophy and personal approach to success.
Read the full piece here. Please join us in congratulating Dr. Hillyer on this well-deserved recognition and thanking him for his leadership of NYBCe and its lifesaving mission.